A detailed history of Citigroup Inc transactions in Glaukos Corp stock. As of the latest transaction made, Citigroup Inc holds 66,852 shares of GKOS stock, worth $10.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
66,852
Previous 35,508 88.27%
Holding current value
$10.1 Million
Previous $4.2 Million 107.26%
% of portfolio
0.01%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$113.62 - $135.39 $3.56 Million - $4.24 Million
31,344 Added 88.27%
66,852 $8.71 Million
Q2 2024

Aug 12, 2024

SELL
$89.48 - $118.35 $1,073 - $1,420
-12 Reduced 0.03%
35,508 $4.2 Million
Q1 2024

May 10, 2024

BUY
$76.4 - $96.33 $506,684 - $638,860
6,632 Added 22.96%
35,520 $3.35 Million
Q4 2023

Feb 09, 2024

BUY
$59.53 - $85.11 $588,037 - $840,716
9,878 Added 51.96%
28,888 $2.3 Million
Q3 2023

Nov 09, 2023

SELL
$69.23 - $79.09 $10.9 Million - $12.5 Million
-158,060 Reduced 89.26%
19,010 $1.43 Million
Q2 2023

Aug 10, 2023

BUY
$45.44 - $71.21 $7.07 Million - $11.1 Million
155,506 Added 721.14%
177,070 $12.6 Million
Q1 2023

May 11, 2023

SELL
$43.88 - $52.48 $305,975 - $365,943
-6,973 Reduced 24.43%
21,564 $1.08 Million
Q4 2022

Feb 09, 2023

SELL
$40.82 - $57.75 $8.28 Million - $11.7 Million
-202,811 Reduced 87.66%
28,537 $1.25 Million
Q3 2022

Nov 10, 2022

BUY
$46.84 - $58.49 $9.87 Million - $12.3 Million
210,752 Added 1023.27%
231,348 $12.3 Million
Q2 2022

Aug 10, 2022

SELL
$34.86 - $63.77 $5.31 Million - $9.72 Million
-152,428 Reduced 88.1%
20,596 $935,000
Q1 2022

May 12, 2022

BUY
$44.33 - $57.82 $6.08 Million - $7.93 Million
137,081 Added 381.38%
173,024 $10 Million
Q4 2021

Feb 10, 2022

BUY
$40.27 - $56.99 $407,612 - $576,852
10,122 Added 39.2%
35,943 $1.6 Million
Q3 2021

Nov 10, 2021

BUY
$47.43 - $84.23 $1.22 Million - $2.17 Million
25,821 New
25,821 $1.24 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.2B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.